Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medifast (MED) Tax Provisions (2016 - 2025)

Medifast (MED) has disclosed Tax Provisions for 16 consecutive years, with $11.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Tax Provisions rose 2355.44% year-over-year to $11.7 million, compared with a TTM value of $13.0 million through Dec 2025, up 676.7%, and an annual FY2025 reading of $13.0 million, up 666.65% over the prior year.
  • Tax Provisions was $11.7 million for Q4 2025 at Medifast, up from -$404000.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $14.4 million in Q2 2021 and bottomed at -$2.5 million in Q2 2024.
  • Average Tax Provisions over 5 years is $6.8 million, with a median of $7.4 million recorded in 2022.
  • Peak annual rise in Tax Provisions hit 2355.44% in 2025, while the deepest fall reached 201.0% in 2025.
  • Year by year, Tax Provisions stood at $12.7 million in 2021, then crashed by 53.72% to $5.9 million in 2022, then plummeted by 36.06% to $3.8 million in 2023, then tumbled by 87.31% to $478000.0 in 2024, then surged by 2355.44% to $11.7 million in 2025.
  • Business Quant data shows Tax Provisions for MED at $11.7 million in Q4 2025, -$404000.0 in Q3 2025, and $400000.0 in Q2 2025.